Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
CNMD CONMED Corp
- Stocks
- Healthcare
- NASDAQ: CNMD
Price (delayed)
$60.73
Market cap
$1.88B
P/E Ratio
15.82
Dividend/share
$0.8
EPS
$3.84
Enterprise value
$2.74B
CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties,
Highlights
The stock's price to earnings (P/E) is 97% less than its 5-year quarterly average of 467.0 and 10% less than its last 4 quarters average of 17.5
CNMD's equity is up by 14% YoY
The net income is up by 44% year-on-year but it has declined by 10% since the previous quarter
CNMD's EPS is up by 43% YoY but it is down by 10% QoQ
CNMD's quick ratio is down by 3.2% QoQ and by 3.2% YoY
Key stats
What are the main financial stats of CNMD
Market
Valuations
Earnings
Shares outstanding
30.94M
Market cap
$1.88B
Enterprise value
$2.74B
Price to earnings (P/E)
15.82
Price to book (P/B)
1.92
Price to sales (P/S)
1.43
EV/EBIT
15.09
EV/EBITDA
13.81
EV/Sales
2.08
Revenue
$1.32B
Gross profit
$738.82M
Operating income
$181.27M
Net income
$118.75M
EBIT
$181.27M
EBITDA
$198.07M
Free cash flow
$164.55M
Per share
Balance sheet
Liquidity
EPS
$3.84
EPS diluted
$3.8
Free cash flow per share
$5.31
Book value per share
$31.63
Revenue per share
$42.49
TBVPS
$28.48
Total assets
$2.3B
Total liabilities
$1.32B
Debt
$892.16M
Equity
$977.64M
Working capital
$355.85M
Debt to equity
0.91
Current ratio
2.26
Quick ratio
0.91
Net debt/EBITDA
4.33
Margins
Efficiency
Dividend
EBITDA margin
15.1%
Gross margin
56.1%
Net margin
9%
Operating margin
13.8%
Return on assets
5.2%
Return on equity
12.6%
Return on invested capital
12.2%
Return on capital employed
9%
Return on sales
13.8%
Dividend yield
1.32%
DPS
$0.8
Payout ratio
20.8%
CNMD stock price
How has the CONMED stock price performed over time
Intraday
6.39%
1 week
6.6%
1 month
17.4%
1 year
-14.66%
YTD
-11.27%
QTD
0.56%
Financial performance
How have CONMED's revenue and profit performed over time
Revenue
$1.32B
Gross profit
$738.82M
Operating income
$181.27M
Net income
$118.75M
Gross margin
56.1%
Net margin
9%
The net income is up by 44% year-on-year but it has declined by 10% since the previous quarter
The company's net margin rose by 38% YoY but it fell by 11% QoQ
The operating income has increased by 27% year-on-year but it has declined by 10% since the previous quarter
The operating margin has grown by 22% year-on-year but it has declined by 10% since the previous quarter
Price vs fundamentals
How does CNMD's price correlate with its fundamentals
Growth
What is CONMED's growth rate over time
Valuation
What is CONMED stock price valuation
P/E
15.82
P/B
1.92
P/S
1.43
EV/EBIT
15.09
EV/EBITDA
13.81
EV/Sales
2.08
The stock's price to earnings (P/E) is 97% less than its 5-year quarterly average of 467.0 and 10% less than its last 4 quarters average of 17.5
CNMD's EPS is up by 43% YoY but it is down by 10% QoQ
The stock's price to book (P/B) is 51% less than its 5-year quarterly average of 3.9 and 13% less than its last 4 quarters average of 2.2
CNMD's equity is up by 14% YoY
CNMD's P/S is 51% less than its 5-year quarterly average of 2.9 and 11% less than its last 4 quarters average of 1.6
CNMD's revenue is up by 4.3% year-on-year
Efficiency
How efficient is CONMED business performance
CNMD's return on assets is up by 44% year-on-year but it is down by 9% since the previous quarter
CNMD's return on invested capital is up by 27% year-on-year but it is down by 8% since the previous quarter
The ROE has grown by 25% YoY but it has contracted by 14% from the previous quarter
CNMD's ROS is up by 22% YoY but it is down by 10% QoQ
Dividends
What is CNMD's dividend history
DPS
$0.8
Dividend yield
1.32%
Payout ratio
20.8%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did CONMED financials performed over time
CNMD's total assets is 74% greater than its total liabilities
The total liabilities has declined by 9% year-on-year
The current ratio has grown by 3.7% YoY
The company's debt is 9% lower than its equity
The company's debt to equity fell by 22% YoY and by 3.2% QoQ
CNMD's equity is up by 14% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.